SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection

被引：0
|
作者：
Gragnano, Felice [1 ,2 ]
Terracciano, Fabrizia [1 ,2 ]
Calabro, Paolo [1 ,2 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Viale Abramo Lincoln 5, IT-81100 Caserta, Italy
[2] AORN St Anna & San Sebastiano, Div Clin Cardiol, F Palasciano, IT-81100 Caserta, Italy
来源：
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH | 2024年 / 17卷 / 01期
关键词：
OUTCOMES;
D O I：
10.1007/s12265-023-10415-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：227 / 229
页数：3
相关论文
共 50 条
  • [21] SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
    Seidu, Samuel
    Alabraba, Vicki
    Davies, Sarah
    Newland-Jones, Philip
    Fernando, Kevin
    Bain, Stephen C.
    Diggle, Jane
    Evans, Marc
    James, June
    Kanumilli, Naresh
    Milne, Nicola
    Viljoen, Adie
    Wheeler, David C.
    Wilding, John P. H.
    [J]. DIABETES THERAPY, 2024, 15 (05) : 1099 - 1124
  • [22] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Clifford J. Bailey
    Caroline Day
    Srikanth Bellary
    [J]. Current Diabetes Reports, 2022, 22 : 39 - 52
  • [23] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Bailey, Clifford J.
    Day, Caroline
    Bellary, Srikanth
    [J]. CURRENT DIABETES REPORTS, 2022, 22 (01) : 39 - 52
  • [24] Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
    O'Hara, D. V.
    Neuen, B. L.
    Jardine, M. J.
    [J]. JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 977 - 983
  • [25] Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
    D. V. O’Hara
    B. L. Neuen
    M. J. Jardine
    [J]. Journal of Nephrology, 2020, 33 : 977 - 983
  • [26] Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
    Liu, Ban
    Wang, Yuliang
    Zhang, Yangyang
    Yan, Biao
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (20) : 1818 - 1849
  • [27] Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance
    Ray, Evan C.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 11 - 17
  • [28] Renal effects of SGLT2 inhibitors: an update
    Nespoux, Josselin
    Vallon, Volker
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (02): : 190 - 198
  • [29] Renal and cardiac effects of SGLT2 inhibitors
    Menne J.
    [J]. Der Nephrologe, 2017, 12 (2): : 90 - 96
  • [30] Response to letter to the editor regarding the article "SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis" Cardiac, renal protection with SGLT2 inhibitors is evident but not in every diabetic patient
    Barbarawi, Mahmoud
    Barbarawi, Owais
    Chen, Kai
    [J]. HEART FAILURE REVIEWS, 2022, 27 (04) : 1469 - 1469
12345